Current Neuropharmacology aims to provide current, comprehensive/mini-reviews. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. Moreover, position papers and research articles/clinical trials of great novelty and scientific interest might occasionally be considered for publication, along with guest-edited issues in all areas of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

“Current Nutraceuticals” publishes original research articles, mini- and full-length reviews, feature articles, technical notes and thematic issues covering all aspects of nutraceuticals, from the isolation and comprehensive characterization of secondary metabolites and their synthesis to the biological activity of nutritional constituents and antioxidants, clinical, population, ethnological and agricultural studies. The journal also explicitly welcomes interdisciplinary contributions considering wider social, cultural, ethical and applied aspects of nutraceuticals and nutrition in modern society.
●      Isolation and comprehensive chemical and physical characterization of active ingredients
●      Secondary metabolites from plants and (micro-)organisms
●      Antioxidants
●      Chemoprevention
●      Biomarkers of nutrition and health
●      Chemistry of nutraceuticals, including synthesis
●      Nutrition and ageing
●      Nutrition and lifestyle
●      Nutraceuticals and drug development
●      Nutraceuticals in agriculture
●      Healthy diets
●      Nutraceuticals in Society: Wider cultural, social, ethical, ecological and economic implications

Current Organic Chemistry aims to provide in-depth/mini-reviews on the current progress in various fields related to organic chemistry, including bioorganic chemistry, organo-metallic chemistry, asymmetric synthesis, heterocyclic chemistry, natural product chemistry, catalytic and green chemistry, up-to-date synthetic approaches, flow chemistry, suitable aspects of medicinal chemistry and polymer chemistry, as well as analytical methods in organic chemistry. It also covers topics related to structures, properties and reactivities of synthetic and natural organic compounds, and to reaction mechanisms. Articles related to hydrocarbons are also included.
The frontier reviews provide the current state of knowledge in these fields and are written by selected experts who are internationally known for their outstanding research contributions. The journal also accepts high-quality research papers focusing on hot topics, highlights, and letters besides thematic issues in these fields. Current Organic Chemistry should prove to be of great interest to organic chemists in academia and industry, who wish to keep abreast with recent developments in key fields of organic chemistry.

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. The journal covers organo homogeneous/heterogeneous catalysis, innovative mechanistic studies and kinetics of organocatalytic processes focusing on practical, theoretical and computational aspects. It also includes potential applications of organocatalysts in the fields of drug discovery, synthesis of novel molecules, synthetic method development, green chemistry and chemoenzymatic reactions.
This journal also accepts papers on methods, reagents, and mechanism of a synthetic process and technology pertaining to chemistry. Moreover, this journal features full-length/mini review articles within organocatalysis and synthetic chemistry. It is the premier source of organocatalysis and synthetic methods related information for chemists, biologists and engineers pursuing research in industry and academia.
Current Organocatalysis is an international, peer-reviewed journal on all aspects of organocatalysis, published quarterly (print and online) by Bentham Science Publishers.

Current Pharmaceutical Analysis publishes authoritative reviews, written by experts in the field on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary, peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in all areas of pharmacology. Special consideration is given to articles on pharmacogenomics and personalized medicine. CPPM is an accelerator for global personalized medicine and pharmacogenomics, as well as preclinical and clinical pharmacology. Importantly, the journal provides a multi-disciplinary, integrated platform from cell to society to address diagnostics and the responsible pharmacogenomics applications in developing countries and the entire range of translational science from bench to bedside in various therapeutic areas, such as oncology, neuropharmacology, and cardiovascular and endocrine diseases, amongst others.
CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer-reviewed contributions from authors in any global region.
The journal's scope is defined by four interconnected aims. First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics) as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention and can be substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions, such as nutrition, vaccines, surgical devices, and emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy, and social studies of biotechnology, which collectively shape postgenomics future(s) and innovation trajectories in life sciences. Fourth, we are interested in all aspects of translational pharmacology, from preclinical to clinical applications in any therapeutic area that will advance the practice of medicine for the benefit of patients worldwide, including non-communicable diseases as well as infectious diseases in the post-COVID world.
Priority will be given to expert reviews/ mini-reviews and research articles that include original ideas and findings related to the scope and mandate of the journal. Unsolicited submissions are welcome.
Current Pharmacogenomics and Personalized Medicine is an international, peer-reviewed journal on all aspects of pharmacogenomics and personalized medicine published continuously (print & online) by Bentham Science Publishers.

The journal publishes original research articles, letters, case reports, reviews/mini-reviews, editorials, commentaries, perspectives, letters to the editor, and guest edited thematic issues in various topics related to physics.
It is not limited to any one aspect of a specific field but focuses on a wide range of sub-fields within that field. Articles with interdisciplinary features are especially popular. Articles in the following fields are of particular interest to the readers of this journal:
●     Astronomy and Astrophysics
●     Atmospheric Physics
●     Atomic and Molecular Physics And Optics
●     Biophysics
●     Chemical Physics
●     Electromagnetism
●     Experimental Physics
●     General Physics
●     Geophysics and Planetology
●     Instrumentation
●     Medical Physics
●     Soft Matter Physics
●     Modern Cosmology
●     Nature Physics
●     Nuclear and High Energy Physics
●     Quantum Physics
●     Radiation
●     Statistical and Nonlinear Physics
●     Surfaces and Interfaces
●     Thermal Physics

Current Protein & Peptide Science publishes full-length/mini review articles on specific aspects involving proteins, peptides, and interactions between the enzymes, the binding interactions of hormones and their receptors; the properties of transcription factors and other molecules that regulate gene expression; the reactions leading to the immune response; the process of signal transduction; the structure and function of proteins involved in the cytoskeleton and molecular motors; the properties of membrane channels and transporters; and the generation and storage of metabolic energy. In addition, reviews of experimental studies of protein folding and design are given special emphasis. Manuscripts submitted to Current Protein and Peptide Science should cover a field by discussing research from the leading laboratories in a field and should pose questions for future studies. Original papers, research articles and letter articles/short communications are not considered for publication in Current Protein & Peptide Science.